PA549749
CDKN2B Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PA549749-Each-of-1 | In Stock | ₹ 44,277.30 |
PA549749 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,277.30
GST (18%): ₹ 7,969.914
Total Price: ₹ 52,247.214
Antigen
CDKN2B
Classification
Polyclonal
Conjugate
Unconjugated
Gene
CDKN2B
Gene Alias
AV083695; CDK inhibitory protein; CDK4B inhibitor; CDK4I; Cdkn2b; cyclin dependent kinase inhibitor 2B; Cyclin dependent kinase inhibitor 2B (p15, inhibits CDK4); cyclin-dependent kinase 4 inhibitor B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); cyclin-dependent kinase inhibitor p15; cyclin-dependent kinase inhibitor p15INK4b; cyclin-dependent kinase inhibitor protein; cyclin-dependent kinases 4 and 6 binding protein; Ink4; INK4B; MTS2; MTS-2; Multiple tumor suppressor 2; p14_CDK inhibitor; p14_INK4B; p14-INK4b; P15; p15 CDK inhibitor; p15(INK4b); p15_INK4B; p15INK4b; p15-INK4b; TP15
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
1030, 12579, 25164
Content And Storage
-20°C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
P42772, P55271, P55272
Gene Symbols
CDKN2B
Immunogen
Synthesized peptide derived from human p15 INK antibody.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Description
- The antibody detects endogenous levels of total CDKN2B protein
- The four known 15-to 19 kDa INK4 proteins (p15INK4b, p16INK4a, p18INK4c andp19INK4d) bind and inhibit CDK4 and CDK6 but not other CDKs, including cyclin E-Cdk2, cyclin A-Cdk2 and cyclin B-Cdk1
- Like the three D-type cyclins, the INK4 genes are expressed in distinct tissue-specific patterns, suggesting that they are not strictly redundant
- 5 p18INK4c is expressed during G1 to S transition in the eukaryotic cell division cycle
- It is maximally induced as cells enter S-phase.
Compare Similar Items
Show Difference
Antigen: CDKN2B
Classification: Polyclonal
Conjugate: Unconjugated
Gene: CDKN2B
Gene Alias: AV083695; CDK inhibitory protein; CDK4B inhibitor; CDK4I; Cdkn2b; cyclin dependent kinase inhibitor 2B; Cyclin dependent kinase inhibitor 2B (p15, inhibits CDK4); cyclin-dependent kinase 4 inhibitor B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); cyclin-dependent kinase inhibitor p15; cyclin-dependent kinase inhibitor p15INK4b; cyclin-dependent kinase inhibitor protein; cyclin-dependent kinases 4 and 6 binding protein; Ink4; INK4B; MTS2; MTS-2; Multiple tumor suppressor 2; p14_CDK inhibitor; p14_INK4B; p14-INK4b; P15; p15 CDK inhibitor; p15(INK4b); p15_INK4B; p15INK4b; p15-INK4b; TP15
Host Species: Rabbit
Purification Method: Antigen affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 1030, 12579, 25164
Content And Storage: -20°C
Form: Liquid
Applications: Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: P42772, P55271, P55272
Gene Symbols: CDKN2B
Immunogen: Synthesized peptide derived from human p15 INK antibody.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Mouse, Rat
Product Type: Antibody
Isotype: IgG
Antigen:
CDKN2B
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
CDKN2B
Gene Alias:
AV083695; CDK inhibitory protein; CDK4B inhibitor; CDK4I; Cdkn2b; cyclin dependent kinase inhibitor 2B; Cyclin dependent kinase inhibitor 2B (p15, inhibits CDK4); cyclin-dependent kinase 4 inhibitor B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); cyclin-dependent kinase inhibitor p15; cyclin-dependent kinase inhibitor p15INK4b; cyclin-dependent kinase inhibitor protein; cyclin-dependent kinases 4 and 6 binding protein; Ink4; INK4B; MTS2; MTS-2; Multiple tumor suppressor 2; p14_CDK inhibitor; p14_INK4B; p14-INK4b; P15; p15 CDK inhibitor; p15(INK4b); p15_INK4B; p15INK4b; p15-INK4b; TP15
Host Species:
Rabbit
Purification Method:
Antigen affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
1030, 12579, 25164
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
P42772, P55271, P55272
Gene Symbols:
CDKN2B
Immunogen:
Synthesized peptide derived from human p15 INK antibody.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Mouse, Rat
Product Type:
Antibody
Isotype:
IgG
Antigen: Cyclin L1
Classification: Polyclonal
Conjugate: Unconjugated
Gene: Ccnl1
Gene Alias: 2610030E23Rik; ANIA6A; ania-6a; AU018493; BM-001; Ccn1; Ccnl; CCNL1; Cyclin Ania-6a; cyclin L ania-6a; cyclin L gamma; cyclin L1; cyclin-L; Cyclin-L1; LOW QUALITY PROTEIN: cyclin-L1; PRO1073; UNQ530/PRO1073
Host Species: Rabbit
Purification Method: Antigen affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 114121, 56706, 57018
Content And Storage: -20°C
Form: Liquid
Applications: Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: Q52KE7, Q9R1Q2, Q9UK58
Gene Symbols: Ccnl1
Immunogen: Synthesized peptide derived from human Cyclin-L1.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Mouse, Rat
Product Type: Antibody
Isotype: IgG
Antigen:
Cyclin L1
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
Ccnl1
Gene Alias:
2610030E23Rik; ANIA6A; ania-6a; AU018493; BM-001; Ccn1; Ccnl; CCNL1; Cyclin Ania-6a; cyclin L ania-6a; cyclin L gamma; cyclin L1; cyclin-L; Cyclin-L1; LOW QUALITY PROTEIN: cyclin-L1; PRO1073; UNQ530/PRO1073
Host Species:
Rabbit
Purification Method:
Antigen affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
114121, 56706, 57018
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
Q52KE7, Q9R1Q2, Q9UK58
Gene Symbols:
Ccnl1
Immunogen:
Synthesized peptide derived from human Cyclin-L1.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Mouse, Rat
Product Type:
Antibody
Isotype:
IgG
Antigen: Sodium Channel Pan
Classification: Polyclonal
Conjugate: Unconjugated
Gene: SCN1A
Gene Alias: 3-Feb; 6430408L10; A230052E19Rik; AI853486; alternative product; ataxia 3; B230332M13; BFIC3; BFIS3; BFNIS; brain III voltage-gated sodium channel; C630029C19Rik; cardiac tetrodotoxin-insensitive voltage-dependent sodium channel alpha subunit; CDCD2; CERIII; CIAT; CMD1E; CMPD2; CMS16; CTC-264K15.6; dmu; EIEE11; EIEE13; EIEE6; ETHA; FEB3; FEB3A; FEB3B; FEPS2; FEPS3; FHM3; GEFSP2; GEFSP7; Gm1000; HB1; HB2; HBA; HBBD; HBSC II; HBSCI; HBSCII; HH1; hNa6/Scn8a voltage-gated sodium channel; hNaN; hNE-Na; HOKPP2; hPN3; HSAN2D; HSAN7; HYKPP; HYPP; ICCD; IVF; KIAA1356; Kiaa4197; LQT3; med; mH1; mH2; microI; mKIAA4197; mnd2; mnd-2; Mu-1; Na(v)1.2; Na(V)1.4; Na(V)1.8; Na+ channel; NAC1; NAC1A; NAC2; NAC3; naCh6; NachII; NaN; NaT; Nav1.1; Nav1.2; Nav1.3; Nav1.4; Nav1.5; Nav1.5c; Nav1.6; Nav1.7; Nav1.8; NaV1.9; Nbna1; NCHVS; NENA; NE-NA; Neuroendocrine sodium channel; nmf2; nmf335; nmf58; NSS2; nur14; Peripheral nerve protein type 4; peripheral nerve sodium channel 3; Peripheral nerve sodium channel 5; peripheral sodium channel 1; PFHB1; PN1; PN3; PN4; PN5; RII/RIIA; RIIA sodium channel protein; RNSCPIIR; SCAL; SCIII; SCN; SCN1; SCN10A; SCN11A; SCN12A; SCN1A; SCN2A; SCN2A1; SCN2A2; SCN3A; SCN4A; Scn5a; SCN8A; SCN9A; ScpII; seal; Sensory neuron sodium channel; sensory neuron sodium channel 2; SFNP; skeletal muscle sodium channel alpha subunit; skeletal muscle voltage-dependent sodium channel type IV alpha subunit; skM1; SkM2; SMEI; SNS; Sns2; SNS-2; sodium channel 25; sodium channel 6; sodium channel alpha-subunit; sodium channel protein brain I subunit alpha; Sodium channel protein brain II subunit alpha; sodium channel protein brain III subunit alpha; Sodium channel protein cardiac muscle subunit alpha; sodium channel protein skeletal muscle subunit alpha; Sodium channel protein type 1 subunit alpha; sodium channel protein type 10 subunit alpha; Sodium channel protein type 11 subunit alpha; sodium channel protein type 2 subunit alpha; Sodium channel protein type 3 subunit alpha; sodium channel protein type 4 subunit alpha; Sodium channel protein type 5 subunit alpha; sodium channel protein type 8 subunit alpha; Sodium channel protein type 9 subunit alpha; sodium channel protein type I subunit alpha; Sodium channel protein type II subunit alpha; sodium channel protein type III subunit alpha; Sodium channel protein type IV subunit alpha; sodium channel protein type IX subunit alpha; Sodium channel protein type V subunit alpha; sodium channel protein type VIII subunit alpha; Sodium channel protein type X subunit alpha; sodium channel protein type XI subunit alpha; sodium channel protein, brain I alpha subunit; sodium channel protein, brain I subunit alpha; sodium channel protein, brain II subunit alpha; sodium channel protein, brain III subunit alpha; sodium channel protein, brain type 2 alpha subunit; sodium channel type X alpha polypeptide; sodium channel voltage gated type 1 alpha subunit; sodium channel voltage-gated type 11 alpha polypeptide; sodium channel voltage-gated type 4 alpha polypeptide; sodium channel voltage-gated type I alpha polypeptide; sodium channel voltage-gated type II alpha polypeptide; Sodium channel voltage-gated type IV alpha polypeptide; sodium channel voltage-gated type V alpha polypeptide; sodium channel voltage-gated type VIII alpha polypeptide; sodium channel voltage-gated type X alpha polypeptide; sodium channel voltage-gated type XI alpha polypeptide; sodium channel, voltage gated, type I alpha subunit; sodium channel, voltage gated, type II alpha subunit; sodium channel, voltage gated, type III alpha subunit; sodium channel, voltage gated, type IV alpha subunit; sodium channel, voltage gated, type IX alpha subunit; sodium channel, voltage gated, type V alpha subunit; sodium channel, voltage gated, type VIII alpha subunit; sodium channel, voltage gated, type VIII, alpha subunit; sodium channel, voltage gated, type X alpha subunit; sodium channel, voltage gated, type XI alpha subunit
Host Species: Rabbit
Purification Method: Antigen affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 110876, 110880, 11280, 20264, 20265, 20269, 20271, 20273, 20274, 24046, 24766, 25665, 25722, 29571, 29701, 29710, 497770, 6323, 6326, 6328, 6329, 6331, 6334, 6335, 6336, 78956, 81574
Content And Storage: -20°C
Form: Liquid
Applications: Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: A2APX8, O08562, O88420, O88457, P04774, P04775, P08104, P15389, P15390, P35498, P35499, Q14524, Q15858, Q62205, Q62968, Q6QIY3, Q99250, Q9ER60, Q9JJV9, Q9NY46, Q9R053, Q9UI33, Q9UQD0, Q9WTU3, Q9Y5Y9
Gene Symbols: SCN10A, Scn11a, SCN1A, SCN2A, SCN3A, Scn4a, Scn5a, Scn8a, SCN9A
Immunogen: Synthesized peptide derived from human sodium channel.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Mouse, Rat
Product Type: Antibody
Isotype: IgG
Antigen:
Sodium Channel Pan
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
SCN1A
Gene Alias:
3-Feb; 6430408L10; A230052E19Rik; AI853486; alternative product; ataxia 3; B230332M13; BFIC3; BFIS3; BFNIS; brain III voltage-gated sodium channel; C630029C19Rik; cardiac tetrodotoxin-insensitive voltage-dependent sodium channel alpha subunit; CDCD2; CERIII; CIAT; CMD1E; CMPD2; CMS16; CTC-264K15.6; dmu; EIEE11; EIEE13; EIEE6; ETHA; FEB3; FEB3A; FEB3B; FEPS2; FEPS3; FHM3; GEFSP2; GEFSP7; Gm1000; HB1; HB2; HBA; HBBD; HBSC II; HBSCI; HBSCII; HH1; hNa6/Scn8a voltage-gated sodium channel; hNaN; hNE-Na; HOKPP2; hPN3; HSAN2D; HSAN7; HYKPP; HYPP; ICCD; IVF; KIAA1356; Kiaa4197; LQT3; med; mH1; mH2; microI; mKIAA4197; mnd2; mnd-2; Mu-1; Na(v)1.2; Na(V)1.4; Na(V)1.8; Na+ channel; NAC1; NAC1A; NAC2; NAC3; naCh6; NachII; NaN; NaT; Nav1.1; Nav1.2; Nav1.3; Nav1.4; Nav1.5; Nav1.5c; Nav1.6; Nav1.7; Nav1.8; NaV1.9; Nbna1; NCHVS; NENA; NE-NA; Neuroendocrine sodium channel; nmf2; nmf335; nmf58; NSS2; nur14; Peripheral nerve protein type 4; peripheral nerve sodium channel 3; Peripheral nerve sodium channel 5; peripheral sodium channel 1; PFHB1; PN1; PN3; PN4; PN5; RII/RIIA; RIIA sodium channel protein; RNSCPIIR; SCAL; SCIII; SCN; SCN1; SCN10A; SCN11A; SCN12A; SCN1A; SCN2A; SCN2A1; SCN2A2; SCN3A; SCN4A; Scn5a; SCN8A; SCN9A; ScpII; seal; Sensory neuron sodium channel; sensory neuron sodium channel 2; SFNP; skeletal muscle sodium channel alpha subunit; skeletal muscle voltage-dependent sodium channel type IV alpha subunit; skM1; SkM2; SMEI; SNS; Sns2; SNS-2; sodium channel 25; sodium channel 6; sodium channel alpha-subunit; sodium channel protein brain I subunit alpha; Sodium channel protein brain II subunit alpha; sodium channel protein brain III subunit alpha; Sodium channel protein cardiac muscle subunit alpha; sodium channel protein skeletal muscle subunit alpha; Sodium channel protein type 1 subunit alpha; sodium channel protein type 10 subunit alpha; Sodium channel protein type 11 subunit alpha; sodium channel protein type 2 subunit alpha; Sodium channel protein type 3 subunit alpha; sodium channel protein type 4 subunit alpha; Sodium channel protein type 5 subunit alpha; sodium channel protein type 8 subunit alpha; Sodium channel protein type 9 subunit alpha; sodium channel protein type I subunit alpha; Sodium channel protein type II subunit alpha; sodium channel protein type III subunit alpha; Sodium channel protein type IV subunit alpha; sodium channel protein type IX subunit alpha; Sodium channel protein type V subunit alpha; sodium channel protein type VIII subunit alpha; Sodium channel protein type X subunit alpha; sodium channel protein type XI subunit alpha; sodium channel protein, brain I alpha subunit; sodium channel protein, brain I subunit alpha; sodium channel protein, brain II subunit alpha; sodium channel protein, brain III subunit alpha; sodium channel protein, brain type 2 alpha subunit; sodium channel type X alpha polypeptide; sodium channel voltage gated type 1 alpha subunit; sodium channel voltage-gated type 11 alpha polypeptide; sodium channel voltage-gated type 4 alpha polypeptide; sodium channel voltage-gated type I alpha polypeptide; sodium channel voltage-gated type II alpha polypeptide; Sodium channel voltage-gated type IV alpha polypeptide; sodium channel voltage-gated type V alpha polypeptide; sodium channel voltage-gated type VIII alpha polypeptide; sodium channel voltage-gated type X alpha polypeptide; sodium channel voltage-gated type XI alpha polypeptide; sodium channel, voltage gated, type I alpha subunit; sodium channel, voltage gated, type II alpha subunit; sodium channel, voltage gated, type III alpha subunit; sodium channel, voltage gated, type IV alpha subunit; sodium channel, voltage gated, type IX alpha subunit; sodium channel, voltage gated, type V alpha subunit; sodium channel, voltage gated, type VIII alpha subunit; sodium channel, voltage gated, type VIII, alpha subunit; sodium channel, voltage gated, type X alpha subunit; sodium channel, voltage gated, type XI alpha subunit
Host Species:
Rabbit
Purification Method:
Antigen affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
110876, 110880, 11280, 20264, 20265, 20269, 20271, 20273, 20274, 24046, 24766, 25665, 25722, 29571, 29701, 29710, 497770, 6323, 6326, 6328, 6329, 6331, 6334, 6335, 6336, 78956, 81574
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
A2APX8, O08562, O88420, O88457, P04774, P04775, P08104, P15389, P15390, P35498, P35499, Q14524, Q15858, Q62205, Q62968, Q6QIY3, Q99250, Q9ER60, Q9JJV9, Q9NY46, Q9R053, Q9UI33, Q9UQD0, Q9WTU3, Q9Y5Y9
Gene Symbols:
SCN10A, Scn11a, SCN1A, SCN2A, SCN3A, Scn4a, Scn5a, Scn8a, SCN9A
Immunogen:
Synthesized peptide derived from human sodium channel.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Mouse, Rat
Product Type:
Antibody
Isotype:
IgG
Antigen: HAT1
Classification: Polyclonal
Conjugate: Unconjugated
Gene: HAT1
Gene Alias: 2410071B14Rik; AA536933; HAT1; Hat-1; histidine aminotransferase 1; histone acetyltransferase 1; Histone acetyltransferase type B catalytic subunit; histone aminotransferase 1; KAT1
Host Species: Rabbit
Purification Method: Antigen affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 107435, 296501, 8520
Content And Storage: -20°C
Form: Liquid
Applications: Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: O14929, Q5M939, Q8BY71
Gene Symbols: HAT1
Immunogen: Synthesized peptide derived from Internal of human HAT.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Mouse, Rat
Product Type: Antibody
Isotype: IgG
Antigen:
HAT1
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
HAT1
Gene Alias:
2410071B14Rik; AA536933; HAT1; Hat-1; histidine aminotransferase 1; histone acetyltransferase 1; Histone acetyltransferase type B catalytic subunit; histone aminotransferase 1; KAT1
Host Species:
Rabbit
Purification Method:
Antigen affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
107435, 296501, 8520
Content And Storage:
-20°C
Form:
Liquid
Applications:
Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
O14929, Q5M939, Q8BY71
Gene Symbols:
HAT1
Immunogen:
Synthesized peptide derived from Internal of human HAT.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Mouse, Rat
Product Type:
Antibody
Isotype:
IgG